158 related articles for article (PubMed ID: 22415022)
21. Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema.
Noma H; Mimura T; Yasuda K; Shimura M
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1122-8. PubMed ID: 25634982
[TBL] [Abstract][Full Text] [Related]
22. Cytokine Kinetics after Monthly Intravitreal Bevacizumab for Retinal Vein Occlusion Associated with Macular Oedema.
Noma H; Mimura T; Yasuda K; Shimura M
Ophthalmic Res; 2016; 56(4):207-214. PubMed ID: 27160159
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory factors in major and macular branch retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Shimada K
Ophthalmologica; 2012; 227(3):146-52. PubMed ID: 22269605
[TBL] [Abstract][Full Text] [Related]
24. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor and interleukin-6 are correlated with serous retinal detachment in central retinal vein occlusion.
Noma H; Funatsu H; Mimura T
Curr Eye Res; 2012 Jan; 37(1):62-7. PubMed ID: 21978265
[TBL] [Abstract][Full Text] [Related]
26. Aqueous Angiopoietin-Like 4 Levels Correlate With Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion.
Kim JH; Shin JP; Kim IT; Park DH
Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):6-11. PubMed ID: 26746013
[TBL] [Abstract][Full Text] [Related]
27. Vitreous inflammatory factors in macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Harino S; Mimura T; Eguchi S; Hori S
Jpn J Ophthalmol; 2011 May; 55(3):248-255. PubMed ID: 21538003
[TBL] [Abstract][Full Text] [Related]
28. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion.
Lee WJ; Kang MH; Seong M; Cho HY
Br J Ophthalmol; 2012 Nov; 96(11):1426-30. PubMed ID: 22930681
[TBL] [Abstract][Full Text] [Related]
29. Vitreous levels of interleukine-8 and monocyte chemoattractant protein-1 in macular oedema with branch retinal vein occlusion.
Fonollosa A; Garcia-Arumi J; Santos E; Macia C; Fernandez P; Segura RM; Zapata MA; Rodriguez-Infante R; Boixadera A; Martinez-Castillo V
Eye (Lond); 2010 Jul; 24(7):1284-90. PubMed ID: 20111061
[TBL] [Abstract][Full Text] [Related]
30. Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Harino S; Hori S
Eur J Ophthalmol; 2010; 20(2):402-9. PubMed ID: 19967679
[TBL] [Abstract][Full Text] [Related]
31. Vitreous levels of soluble vascular endothelial growth factor receptor (VEGFR)-1 in eyes with vitreoretinal diseases.
Asato R; Kita T; Kawahara S; Arita R; Mochizuki Y; Aiello LP; Ishibashi T
Br J Ophthalmol; 2011 Dec; 95(12):1745-8. PubMed ID: 21719570
[TBL] [Abstract][Full Text] [Related]
32. Changes of aqueous vascular endothelial growth factor and pigment epithelium-derived factor following intravitreal bevacizumab for macular oedema secondary to branch retinal vein occlusion.
Park SP; Ahn JK
Clin Exp Ophthalmol; 2009 Jul; 37(5):490-5. PubMed ID: 19624346
[TBL] [Abstract][Full Text] [Related]
33. Relation of intraocular concentrations of inflammatory factors and improvement of macular edema after vitrectomy in branch retinal vein occlusion.
Okunuki Y; Usui Y; Katai N; Kezuka T; Takeuchi M; Goto H; Wakabayashi Y
Am J Ophthalmol; 2011 Apr; 151(4):610-616.e1. PubMed ID: 21257152
[TBL] [Abstract][Full Text] [Related]
34. Levels of VEGF but not VEGF(165b) are increased in the vitreous of patients with retinal vein occlusion.
Ehlken C; Rennel ES; Michels D; Grundel B; Pielen A; Junker B; Stahl A; Hansen LL; Feltgen N; Agostini HT; Martin G
Am J Ophthalmol; 2011 Aug; 152(2):298-303.e1. PubMed ID: 21621189
[TBL] [Abstract][Full Text] [Related]
35. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
[TBL] [Abstract][Full Text] [Related]
36. Vitreous inflammatory factors and macular oedema.
Funatsu H; Noma H; Mimura T; Eguchi S
Br J Ophthalmol; 2012 Feb; 96(2):302-4. PubMed ID: 20860986
[No Abstract] [Full Text] [Related]
37. Visual acuity and foveal thickness after vitrectomy for macular edema.
Noma H; Funatsu H; Mimura T; Shimada K
Ophthalmologica; 2010; 224(6):367-73. PubMed ID: 20453544
[TBL] [Abstract][Full Text] [Related]
38. Changes of vascular endothelial growth factor after vitrectomy for macular edema secondary to retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Hori S
Eur J Ophthalmol; 2008; 18(6):1017-9. PubMed ID: 18988180
[TBL] [Abstract][Full Text] [Related]
39. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
[TBL] [Abstract][Full Text] [Related]
40. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
